HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- one

inhibits c-Met kinase; structure in first source
Also Known As:
PHA 665752; PHA-665752; PHA665752
Networked: 69 relevant articles (5 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Christensen, James G: 9 articles (02/2011 - 11/2003)
2. Zhao, Zhaolong: 3 articles (03/2018 - 04/2016)
3. Medová, Michaela: 3 articles (02/2013 - 10/2010)
4. Zimmer, Yitzhak: 3 articles (02/2013 - 10/2010)
5. Ahmed, Maqbool: 3 articles (03/2012 - 01/2011)
6. Al-Dayel, Fouad: 3 articles (03/2012 - 01/2011)
7. Al-Kuraya, Khawla S: 3 articles (03/2012 - 01/2011)
8. Bavi, Prashant: 3 articles (03/2012 - 01/2011)
9. Hussain, Azhar R: 3 articles (03/2012 - 01/2011)
10. Uddin, Shahab: 3 articles (03/2012 - 01/2011)

Related Diseases

1. Neoplasms (Cancer)
2. Glioma (Gliomas)
3. Carcinoma (Carcinomatosis)
4. Hepatocellular Carcinoma (Hepatoma)
5. Medulloblastoma

Related Drugs and Biologics

1. Gefitinib (Iressa)
2. Erlotinib Hydrochloride (CP 358,774)
3. ARQ 197
4. JNJ38877605
5. ErbB Receptors (EGF Receptor)
6. Cyclooxygenase 2 (Cyclooxygenase-2)
7. Dynamins (Dynamin)
8. N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazide
9. human ERBB2 protein
10. Proto-Oncogene Proteins c-met

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Radiofrequency Ablation